JCB logo
Fluorescence In Vivo Endomicroscopy
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published 13 March 2006. doi:10.1083/jcb.200601114
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 172, Number 6, 795-797
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 523K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zambetti, G. P.
Right arrow Articles by Schipani, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zambetti, G. P.
Right arrow Articles by Schipani, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Comment

Skeletons in the p53 tumor suppressor closet: genetic evidence that p53 blocks bone differentiation and development

Gerard P. Zambetti1, Edwin M. Horwitz2, and Ernestina Schipani3

1 Department of Biochemistry and 2 Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105
3 Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114

Correspondence to Gerard P. Zambetti: gerard.zambetti{at}stjude.org


Abstract
A series of in vitro tissue culture studies indicated that the p53 tumor suppressor promotes cellular differentiation, which could explain its role in preventing cancer. Quite surprisingly, however, two new in vivo studies (Lengner et al., 2006; Wang et al., 2006) provide genetic evidence that p53 blocks osteoblast differentiation and bone development. These interesting results and their biological and clinical implications are the focus of this comment.

Abbreviations used in this paper: MCSF, macrophage colony–stimulating factor; RANKL, receptor activator of nuclear factor {kappa}B ligand.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents